| |
| |
|
| Insider
Information: |
Doggrell Henry Patton |
| Relationship: |
VP, Chief Legal Officer |
| City: |
Memphis |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
43,630 |
|
|
Indirect Shares
|
4,545 |
|
|
| Direct
Value |
$14,948 |
|
|
|
Indirect Value
|
$1,557 |
|
|
| Total
Shares |
48,175 |
|
|
| Total
Value |
$16,505 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oncternal Therapeutics Inc |
ONCT |
VP, Chief Legal Officer |
2018-06-20 |
43,630 |
2018-06-20 |
4,545 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Legal Officer |
• – – |
2018-06-20 |
4 |
S |
$19.01 |
$139,708 |
D/D |
(7,351) |
43,630 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Legal Officer |
• – – |
2018-01-05 |
4 |
S |
$11.13 |
$56,277 |
D/D |
(4,965) |
50,981 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Legal Officer |
• – – |
2018-01-01 |
4 |
D |
$12.71 |
$55,225 |
D/D |
(4,345) |
55,946 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Legal Officer |
• – – |
2015-05-08 |
4 |
B |
$0.80 |
$20,382 |
I/I |
25,477 |
25,477 |
1.99 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Legal Officer |
• – – |
2015-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
500,000 |
602,913 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Legal Officer |
• – – |
2014-08-08 |
4 |
B |
$0.97 |
$9,746 |
D/D |
10,000 |
102,913 |
2.74 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Legal Officer |
• – – |
2014-06-01 |
4 |
D |
$1.66 |
$44,964 |
D/D |
(27,087) |
92,913 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
VP, Chief Legal Officer |
• – – |
2013-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
120,000 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Vice President and Secretary |
• – – |
2011-03-02 |
4 |
B |
$2.33 |
$17,451 |
I/I |
7,500 |
5,000 |
1.99 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Vice President and Secretary |
• – – |
2008-12-10 |
4 |
S |
$17.04 |
$71,019 |
D/D |
(4,169) |
20,000 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Vice President and Secretary |
• – – |
2008-09-08 |
4 |
S |
$18.43 |
$9,217 |
I/I |
(500) |
4,641 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Vice President and Secretary |
• – – |
2008-08-06 |
4 |
S |
$18.96 |
$189,552 |
D/D |
(10,000) |
24,169 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Vice President and Secretary |
• – – |
2008-05-27 |
4 |
S |
$14.07 |
$140,780 |
D/D |
(10,000) |
34,169 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Vice President and Secretary |
• – – |
2008-02-22 |
4 |
OE |
$12.29 |
$245,800 |
D/D |
20,000 |
44,169 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Vice President and Secretary |
• – – |
2007-07-24 |
4 |
OE |
$14.77 |
$147,700 |
D/D |
10,000 |
24,169 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Vice President and Secretary |
• – – |
2006-05-12 |
4 |
OE |
$6.78 |
$33,900 |
D/D |
5,000 |
14,169 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel and Secretary |
• – – |
2004-08-13 |
4 |
B |
$8.61 |
$4,307 |
I/I |
500 |
5,141 |
1.91 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel and Secretary |
• – – |
2004-08-04 |
4 |
B |
$8.98 |
$23,398 |
I/I |
2,600 |
2,177 |
1.99 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel and Secretary |
• – – |
2004-08-03 |
4 |
B |
$9.33 |
$23,314 |
I/I |
2,500 |
1,000 |
1.99 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel and Secretary |
• – – |
2004-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,169 |
9,169 |
|
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel and Secretary |
• – – |
2004-02-06 |
4/A |
B |
$14.50 |
$14,500 |
I/I |
1,000 |
1,000 |
1.99 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel and Secretary |
• – – |
2004-02-06 |
4 |
B |
$14.50 |
$29,000 |
I/I |
2,000 |
10,169 |
1.99 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
General Counsel and Secretary |
• – – |
2004-02-06 |
4 |
A |
$0.00 |
$0 |
I/I |
5,395 |
877 |
|
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
